Jaguar Health (JAGX) Total Non-Current Liabilities (2014 - 2026)

Jaguar Health's (JAGX) quarterly Total Non-Current Liabilities came in at $53.0 million in Q1 2026, up 375.84% year-on-year from $11.1 million in Q1 2025, and up 111.07% on a QoQ basis from $25.1 million in Q4 2025.

Jaguar Health (JAGX) Total Non-Current Liabilities (2014 - 2026) Analysis & Trends

Jaguar Health (JAGX) has 13 years of Total Non-Current Liabilities data on file, last reported at $53.0 million in Q1 2026.

  • On a quarterly basis, Total Non-Current Liabilities rose 375.84% year-over-year to $53.0 million in Q1 2026; TTM through Mar 2026 was $53.0 million, a 375.84% increase from a year earlier, with the FY2025 full-year figure at $25.1 million, up 176.24% from the prior year.
  • Total Non-Current Liabilities for Q1 2026 stood at $53.0 million, up from $25.1 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for JAGX reached as high as $53.0 million in Q1 2026 and fell as low as $9.1 million in Q4 2024.
  • Historically, Total Non-Current Liabilities has averaged $22.3 million across 5 years, with a median of $14.7 million in 2025.
  • Across the five-year window, Total Non-Current Liabilities sank 63.57% in 2023 and jumped 375.84% in 2026, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $41.0 million in 2022, then sank by 63.57% to $14.9 million in 2023, then slumped by 39.09% to $9.1 million in 2024, then soared by 176.24% to $25.1 million in 2025, then surged by 111.07% to $53.0 million in 2026.
  • Per Business Quant data, the three most recent Total Non-Current Liabilities figures were $53.0 million in Q1 2026, $25.1 million in Q4 2025, and $14.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Nanobiotix 1,782.24 Bn 1,782.18 Bn - 107.80 Mn
2 Akari Therapeutics 1,009.43 Bn 1,009.43 Bn - 19.49 Mn
3 BeOne Medicines 473.46 Bn 468.66 Bn 1.35 Bn 1.98 Bn
4 Vertex Pharmaceuticals 123.84 Bn 116.59 Bn 2.59 Bn 5.87 Bn
5 Regeneron Pharmaceuticals 71.69 Bn 62.94 Bn 3.31 Bn 7.32 Bn
6 Belite Bio 62.15 Bn 62.15 Bn - -
7 Argenx Se 54.74 Bn 49.55 Bn 1.41 Bn 40.00 Mn
8 Alnylam Pharmaceuticals 38.08 Bn 35.07 Bn 959.66 Mn 4.05 Bn
9 Revolution Medicines 36.07 Bn 36.07 Bn - 746.94 Mn
10 Jaguar Health 520,945.88 -9.54 Mn 19.11 Mn 53.00 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 53.00 Mn
Dec 31, 2025 25.11 Mn
Sep 30, 2025 14.69 Mn
Jun 30, 2025 12.58 Mn
Mar 31, 2025 11.14 Mn
Dec 31, 2024 9.09 Mn
Sep 30, 2024 10.09 Mn
Mar 31, 2024 9.13 Mn
Dec 31, 2023 14.92 Mn
Dec 31, 2022 40.97 Mn
Mar 31, 2022 44.80 Mn
Dec 31, 2021 41.41 Mn
Sep 30, 2021 37.70 Mn
Jun 30, 2021 37.75 Mn
Mar 31, 2021 36.81 Mn
Dec 31, 2020 25.64 Mn
Sep 30, 2020 28.30 Mn
Jun 30, 2020 21.07 Mn
Mar 31, 2020 15.42 Mn
Dec 31, 2019 14.34 Mn